Nicole Tritta Gallagher
About Nicole Tritta Gallagher
Nicole Tritta Gallagher serves as the Director of Executive Operations at Nimbus Therapeutics in Boston, Massachusetts, a position she has held since 2023. With extensive experience in the biotechnology sector, she has previously worked in various administrative roles at Fulcrum Therapeutics, Abcam, and Aviva Life Insurance.
Work at Nimbus Therapeutics
Nicole Tritta Gallagher has been serving as the Director of Executive Operations at Nimbus Therapeutics since 2023. Located in Boston, Massachusetts, she oversees various operational aspects of the organization. Her role involves strategic planning and coordination of executive functions, contributing to the company's objectives in the biotechnology sector.
Previous Experience in Biotechnology
Before joining Nimbus Therapeutics, Nicole worked at Fulcrum Therapeutics as the Director of Administration from 2021 to 2022. She also held the position of Manager of Administrative Services at Fulcrum Therapeutics from 2017 to 2021. Her experience in these roles has equipped her with a comprehensive understanding of administrative operations within the biotechnology industry.
Career Background
Nicole Tritta Gallagher's career includes various positions that have shaped her expertise in administration and operations. She worked as an Executive Assistant to the General Manager at Abcam from 2015 to 2017. Earlier in her career, she served as an Executive Assistant at Aviva Life Insurance from 2003 to 2007 and as a Manager Assistant at Enterprise Rent-A-Car from 2001 to 2002.
Education and Expertise
Nicole earned her Bachelor of Science degree in Marketing from Salve Regina University, where she studied from 1991 to 1995. Her educational background complements her professional expertise in strategic planning and event management, particularly within the biotechnology sector.
Skills and Competencies
Nicole possesses strong skills in Microsoft Excel and customer service, which enhance her effectiveness in her roles. Her demonstrated history of working closely with CEOs in the biotechnology sector further underscores her capabilities in executive operations and administrative management.